Project Number 5R01AG055422-04 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Anti-Viral therapy in Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) t. Other Researcher and Organization Principal Investigator DEVANAND, DAVANGERE P Principal Investigator First Name DAVANGERE P Principal Investigator Last Name DEVANAND Awardee Organization COLUMBIA UNIVERSITY Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-16-365: Pilot Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01) FY Overall Cost $2,372,211 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Related Resources Clinical Trial Anti-viral Therapy in Alzheimer's Disease
